Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
28th November 2013
Is it Time to Transform our Treatment of Type 2 Diabetes?
This meeting comprised two sessions: the morning session centred around glucagon-like peptide-1 receptor (GLP-1R) agonists and SGLT-2 inhibitors, a new…
28th November 2013
Diabetes Mellitus and Periodontitis: Signs of a Bidirectional Relationship
Periodontitis is a multifactorial, irreversible and cumulative condition, initiated and propagated by bacteria and host factors. The multifactorial…
28th November 2013
Ambulatory Blood Pressure Monitoring and Circadian Rhythm of Blood Pressure in Diabetes Mellitus
Systolic and diastolic blood pressures display a circadian rhythmicity that can be assessed by 24-hour ambulatory blood pressure monitoring and analysed…
28th November 2013
Mortality in Patients with Pad with Respect to Glycaemic Status: A Review
Peripheral arterial disease (PAD) is a manifestation of atherosclerosis. Atherosclerosis is a chronic inflammatory process and nonenzymatic glycation is…
25th November 2013
Oligodendrogenesis After Cerebral Ischaemia and Traumatic Brain Injury
Stroke and traumatic brain injury (TBI) damage white and grey matter. Loss of oligodendrocytes and their myelin, impairs axonal function.
25th November 2013
Mode of Delivery in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearing age. Little is known about…
25th November 2013
Neurorehabilitation After Stroke
Recovery from ischaemic stroke is determined in the acute phase by the lesion impact of ischaemia and subsequently, by functional and structural network…
25th November 2013
Current Essentials in Inflammatory Myopathies
Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising…
21st November 2013
Fertility Preservation Options for Cancer Patients
Survival rates for cancer patients have increased in the last few years due to improvements achieved in cancer therapies.
1st November 2013
Evidence-Based Treatment Planning in mCRC: The Key to Maximising Outcomes
This Roche sponsored satellite symposium was held as part of the European Cancer Congress 2013, and reviewed the current evidence available on treatment…
←
1
2
3
…
872
873
874
875
876
877
878
…
880
881
882
→